Sign inJoin waitlistJoin the waitlist

Sumit Subudhi

Associate Professor · University of Texas M D Anderson Cancer Center

Credentials: · · · · · · ·

History

University of Texas M D Anderson Cancer Center
Present

Memorial Sloan Kettering Cancer Center
2009–2013
New York Presbyterian Hospital-Weill Cornell Medical Center
2007–2009
University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine
2003–2007

Research

Immune checkpoint therapy-current perspectives and future directions
Review · Cell · 2023 · 989 citations
Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade
Cell · 2013 · 823 citations
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Nature Medicine · 2018 · 628 citations

Ana Aparicio
28 papers
Padmanee Sharma
27 papers
BS
Bilal Siddiqui
23 papers · 7 as a fellow
Christopher Logothetis
22 papers
Paul Corn
22 papers
James Allison
18 papers
Jianjun Gao
13 papers
Patricia Troncoso
13 papers
EE
Eleni Efstathiou
8 papers
Sangeeta Goswami
8 papers · 2 as a fellow
YF
Yang-Xin Fu
8 papers
Patrick Pilié
7 papers

Clinical trials

A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy
Principal investigator · Recruiting · Phase 1, Phase 2
M.D. Anderson Cancer Center
2023–2028
Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
2017–2021
Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer
Principal investigator · Completed · Phase 1
M.D. Anderson Cancer Center
2017–2024
Neoadjuvant Listeria or Daratumumab in Prostate Cancer
Principal investigator · Withdrawn · Phase 2
M.D. Anderson Cancer Center
2017–2019